C21 Investments Inc. (CXXIF) Form 6-K — Aug 21, 2026
C21 Investments filed its Q1 FY2027 interim results with revenue of $7.63 million, down 10.8% from $8.55 million a year earlier, while the net loss widened to $1.97 million from $0.76 million as gross margin slipped to 32.5% and operating income swung to a $1.2 million loss on higher deal-related legal fees. The filing confirms the endgame for the standalone company: shareholders approved the Vireo Growth acquisition on August 7, 2026 with 96.58% of votes cast in favor, holders will receive 0.023052 of a Vireo subordinate voting share per C21 share, and closing is expected on or about August 21, 2026 pending court and regulatory approvals.
Key figures
- Revenue
- 7633174
- Cash Position
- 2623416
- Shares Outstanding
- 118678994
- Gross profit
- 2481293
- Expected close
- on or about August 21, 2026
- Total liabilities
- 29345893
- Accumulated deficit
- 82030658
- Gross margin percent
- 32.5
- Vireo exchange ratio
- 0.023052 Vireo subordinate voting shares per C21 common share
- Uncertain tax position
- 14091109
- Working capital surplus
- 1495079
- Total shareholders equity
- 23825268
- Prior year quarter revenue
- 8553373
- Settlement liability current
- 1000000
- Shareholder approval percent
- 96.58% of votes cast (96.48% excluding MI 61-101 votes)
- Cash from operating activities
- 794559
- Convertible debentures outstanding
- 424749
- Vireo arrangement professional fees
- 558501
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.